Ignite Creation Date:
2025-12-24 @ 6:42 PM
Ignite Modification Date:
2026-03-13 @ 11:55 AM
Study NCT ID:
NCT02820857
Status:
COMPLETED
Last Update Posted:
2025-09-03
First Post:
2016-06-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Assessment of the Efficacy of Bevacizumab in Combination With Folfiri as Second-line Treatment in Patients Suffering From an Advanced Inoperable Poorly Differentiated Neuroendocrine Carcinoma of an Unknown or Gastroentero-pancreatic Primary Cancer
Sponsor:
Hospices Civils de Lyon
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-09-04
Start Date Type:
ACTUAL
Primary Completion Date:
2022-08-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-08-24
Completion Date Type:
ACTUAL
First Submit Date:
2016-06-29
First Submit QC Date:
None
Study First Post Date:
2016-07-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-26
Last Update Post Date:
2025-09-03
Last Update Post Date Type:
ESTIMATED